Advances in Cancer Therapy

Kalorama Information
February 1, 2001
394 Pages - SKU: KLI25
OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018
8/25/2014 | published by: GlobalData
OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018 Summary The competitive landscape in the B-cell NHL markets in the US, France, Italy, Germany, Spain and the UK is poised to undergo a dramatic shift  |  read more...
USD 7,995
Chiral Chromatography Column Market by type (Empty, Pre-packed, Analytical, Preparative), Material (Metal, Glass, Plastic), & by Application [GC, LC (HPLC, UHPLC, Flash Chromatoraphy, UFLC), TLC,SFC] - Forecast to 2018
9/2/2014 | published by: MarketsandMarkets
Chiral Chromatography Column Market by type (Empty, Pre-packed, Analytical, Preparative), Material (Metal, Glass, Plastic), & by Application [GC, LC (HPLC, UHPLC, Flash Chromatoraphy, UFLC), TLC,SFC] - Forecast to 2018 Over the years, the chiral  |  read more...
USD 4,650
Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide
9/9/2014 | published by: Renub Research
Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide Breast cancer is the most common cancer among women in both the developed and developing world. Worldwide Breast Cancer Screening Market was  |  read more...
USD 1,490
EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023
8/25/2014 | published by: GlobalData
EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023 Summary Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small  |  read more...
USD 3,995
Colon Carcinoma - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Colon Carcinoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Colon Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Colon Carcinoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Colon  |  read more...
USD 2,000
Cervical Cancer - Pipeline Review, H2 2014
8/31/2014 | published by: Global Markets Direct
Cervical Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cervical Cancer - Pipeline Review, H2 2014’, provides an overview of the Cervical Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cervical  |  read more...
USD 2,000
Global Hodgkins Lymphoma Therapeutics Market : 2014-2018
8/6/2014 | published by: TechNavio - Infiniti Research Ltd.
Press Release TechNavio Announces the Publication of its Research Report - Global Hodgkins Lymphoma Therapeutics Market 2014-2018 TechNavio recognizes the following companies as the key players in the Global Hodgkins Lymphoma Therapeutics Market : Commenting on the report,  |  read more...
USD 2,500
Biotechnology, Nordic Region
8/12/2014 | published by: Plimsoll Publishing Ltd.
Biotechnology Nordic Analysis displays a summary of the Biotechnology Nordic market and presents a comprehensive individual analysis on the top 250 companies, including ASTRAZENECA AB, ALK-ABELLO A/S and PFIZER AS. This report (compiled in  |  read more...
USD 1,050
Oncology Research Digest H1 2014
8/8/2014 | published by: The Business Research Company
Oncology Research Digest H1 2014 The Oncology Research Digest is a digest of all the most important research in the oncology market each quarter, and available as an annual subscription. It covers  |  read more...
USD 1,000
Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies
8/14/2014 | published by: FirstWord
Introduction As the oncology drug market continues to face significant road bumps in terms of development costs and pricing requirements, the role of Medical Affairs teams working with oncologists becomes ever more critical. Fine tuning their performance  |  read more...
USD 3,900
 

SELECT A LICENSE

    Online Download  USD 350  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!